Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach

Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Other: Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test Sponsors: Fudan University; Shanghai Weihe Medical Laboratory Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials